FDA DEVICE FACTS
KOSMO Femoral Stem
B-One Ortho, Corp.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
T he b-ONE TM Total Hip System is intended for primary or revision total hip replacement in skeletally mature patients wit h a severely disabled h ip joint and/or hip damage due to the following conditions: Osteoarthritis, traumatic arthritis, avascular necrosis of the femoral head, noninflammatory degenerative joint disease (NI D JD), slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. H ip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis and congenital dysplasia; treatmen ts of nonunion, acute traumatic fracture o f the femoral head or neck; failed endoprosthesis, femoral osteotomy, or Gi rdlestone resection; and fracture-dislocation of the hip. The b-ONE TM Total Hip System KOSMO TM HA coated st ems are intended for cementless use only. The b-ONETM Total Hip System KOSMOTM stainless steel stems are intended for cemented use only. b-ONE TM Total Hip System components are not intended for use with other total hip systems.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。